Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/41493
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBONNECHERE, Bruno-
dc.date.accessioned2023-10-09T12:21:38Z-
dc.date.available2023-10-09T12:21:38Z-
dc.date.issued2023-
dc.date.submitted2023-10-04T12:33:08Z-
dc.identifier.citationLancet Haematology, 10 (10) , p. e793 -e794-
dc.identifier.urihttp://hdl.handle.net/1942/41493-
dc.language.isoen-
dc.titleSickle cell disease strategies and priorities-
dc.typeJournal Contribution-
dc.identifier.epagee794-
dc.identifier.issue10-
dc.identifier.spagee793-
dc.identifier.volume10-
local.bibliographicCitation.jcatA2-
local.type.refereedRefereed-
local.type.specifiedLetter-
dc.identifier.doi10.1016/S2352-3026(23)00266-1-
local.provider.typeCrossRef-
local.uhasselt.internationalno-
item.accessRightsClosed Access-
item.fullcitationBONNECHERE, Bruno (2023) Sickle cell disease strategies and priorities. In: Lancet Haematology, 10 (10) , p. e793 -e794.-
item.fulltextNo Fulltext-
item.contributorBONNECHERE, Bruno-
crisitem.journal.issn2352-3026-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.